Sanyal A, Yoon S, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15:14–22.
Rai G, Mishra S, Suman S, Shukla Y. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight. Phytomedicine. 2016;23:233.
Article CAS PubMed Google Scholar
Torre A, Bray F, Siegel R, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics 2012. CA Cancer J Clin. 2015;65:87.
Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Rossi JZ, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.
Abdelfattah-Hassan A, Shalaby IS, Khater SI, El-Shetry SE, El Fadil HA, Elsayed SA. Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage. Complement Ther Med. 2019;46:95–102.
Gutiérrez-Rebolledo GA, Siordia-Reyes AG, Meckes-Fischer M, Jiménez-Arellanes A. Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damage. Asian Pac J Trop Med. 2016;9(7):644–51.
Rodeiro D, Fernandez S, Rodriguez A, Gonzalez L. La creación de empresas en el ámbito universitario: una aplicación de la teoría de los recursos. Cuadernos de Gestión. 2008;8:11–28.
Zhang L, Gu F, Chan J, Wang A, Langer R, Farokhzad O. Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther. 2008;83:76.
Balbatina LA, Stolyarova OV, Kondratenko RM, Plyasunova OA, Pokrovskii AG. L.A.Synthesis and antiviral activity of 18α-glycyrrhizic acid and its esters. Pharm Chem J. 2010;44(6):299–302.
Salmine A, Lehtonen M, Suuronen T, Kaarniranta K, Huuskonen J. Terpenoids: natural inhibitors of NK-κB signaling with anti-inflammatory and anticancer potential. Cell Mol Life Sci. 2008;65(19):2979–99.
Kim KJ, Choi JS, Kim KW, Jeong JW. The anti-angiogenic activities of glycyrrhizic acid in tumor progression. Phytother Res. 2013;27(6):841–6.
Graebin CS. The pharmacological activities of glycyrrhizinic acid (“Glycyrrhizin”) and glycyrrhetinic acid. In: Mérillon JM, Ramawat KG, editors. Sweeteners. Reference Series in Phytochemistry. Springer, Cham., Switzerland, 2018:245–61.
Groen J, Pelser H, Frenkel M, Kamminga CE, et al. Effect of glycyrrhizinic acid on the electrolyte metabolism in Addison’s disease. J Clin Investig. 1951;31(1):87–91.
Ruiz MCR, Amer H, Stanetty C, Beseda I, Czollner L, Shah P, Jordis U, Kueenburg B, ClaBen-Houben D, Hofinger A, Kosma P. Efficient synthesis of glycyrrhetinic acid glycoside/glucuronide derivatives using silver zeolite as promoter. Carbohyd Res. 2009;344(9):1063–71.
Amagaya S, Sugishita E, Ogihara Y, Ogawa S, Okada K, Aizawa T. Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities. J Pharmacobiodyn. 1984;7(12):923–8.
Article CAS PubMed Google Scholar
Davis EA, Morris DJ. Medicinal Uses of Licorice Through the Millennia: the Good and Plenty of It. Mol Cell Endocrinol. 1991;78(1–2):1–6.
Article CAS PubMed Google Scholar
Fiore C, Eisenhut M, Ragazzi E, Zanchin G, Armanini D. A History of the Therapeutic Use of Liquorice in Europe. J Ethnopharmacol. 2005;99(3):317–24.
Article PubMed PubMed Central Google Scholar
MonteirodoNascimiento MH, RibeirodeAraújo D. Exploring the Pharmacological Potential of Glycyrrhizic Acid: From Therapeutic Applications to Trends in Nanomedicine. Future Pharmacol. 2022;2(1):1–15.
Bharali DJ, Mousa SA. Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise. Pharmacol Ther. 2010;128:324–35.
Article CAS PubMed Google Scholar
Gindy ME, Prud’homme RK. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv. 2009;6(8):865–78.
Article CAS PubMed Google Scholar
Perioli L, Ambrogi V, Di Nauta L, Nocchetti M, Rossi C. Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen. Appl Clay Sci. 2011;51:407–13.
Arcoa M, Gutiérrez S, Martína C, Rivesa V. Synthesis and characterization of layered double hydroxides (LDH) intercalated with non-steroidal anti-inflammatory drugs (NSAID). J Solid State Chem. 2004;177:3954–62.
Nakayama H, Hatakeyama A, Tsuhako M. Encapsulation of nucleotides and DNA into Mg-Al layered double hydroxide. Int J Pharm. 2010;393:105–12.
Rives V. Layered Double Hydroxides: Present and Future. New York: Nova Science Publishers Inc; 2001.
Duan X, Evans DG. Layered double hydroxides. Structure and bonding. Springer-Verlag Berlin Heidelberg, Germany, 2006, p. 234.
Cavani F, Trifiró F, Vaccari A. Hydrotalcite-like anionic clays: preparation, properties and applications. Catal Today. 1991;11:173–301.
Choi SJ, Choy JH. Effect of physico-chemical parameters on the toxicity of inorganic nanoparticles. J Mater Chem. 2011;21:5547–54.
Choi SJ, Choy JH. Layered double hydroxide nanoparticles as target-specific delivery carriers: Uptake mechanism and toxicity. Nanomedicine. 2011;6:803–14.
Article CAS PubMed Google Scholar
Rives V, Arco M, Martín C. Intercalation of drugs in layered double hydroxides and their controlled release: A review. Appl Clay Sci. 2014;88:239–69.
Wenji J, Dongki L, Yukwon J, Dae-Hwan P. Biocompatible Hydrotalcite Nanohybrids for Medical Functions. Minerals. 2020;10:172.
Wiyantoko B, Kurniawati P, Purbaningtias TE, Fatimah I. Synthesis and Characterization of Hydrotalcite at Different Mg/Al Molar Ratios. Procedia Chemistry. 2015;17:21–6.
Wang Q, Wu Z, Huang Tay H, Chen L, Liu Y, Chang J, Zhong Z, Luo J, Borgna A. High temperature adsorption of CO2 on Mg–Al hydrotalcite: Effect of the charge compensating anions and the synthesis pH. Catal Today. 2011;164:198–203.
Kwon D, Kang JY, An S, Yang I, Jung JC. Tuning the base properties of Mg–Al hydrotalcite catalysts using their memory effect. J Energy Chem. 2020;45:229–36.
Trujillo R, Labajos FM, Rives V. Hydrotalcites, a rapid survey on the very recent synthesis and applications procedures. Appl Clay Sci. 2023;238(15):106927.
Yang G, Lin W, Lai H, Tong J, Lei J, Yuan M, Zhang Y, Cuia C. Understanding the relationship between particle size and ultrasonic treatment during the synthesis of metal nanoparticles. Ultrason Sonochemistry. 2021;73:105497.
Dumortier G, Grossiord J, Agnely F, Chaumeil J. A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics. Pharm Res. 2006;23:2709–28.
Article CAS PubMed Google Scholar
Almeida M, Magalhães M, Veiga F, Figueiras A. Poloxamers, poloxamines and polymeric micelles: Definition, structure and therapeutic applications in cancer. J Polym Res. 2018;25:31.
Bo-Kyung K, Gyeong-Hyeon G, Tomohiko O, Jae-Min O. Effect of particle size and local disorder on specific surface area of layered double hydroxides upon calcination-reconstruction. J Solid State Chem. 2018;263:60–4.
Ćirin D, Veljko K, Mihalj P. Properties of poloxamer 407 and polysorbate mixed micelles: Influence of polysorbate hydrophobic chain. J Ind Eng Chem. 2017;47:194–201.
Gorjian H, Mihankhah P, Khaligh NG. Influence of tween nature and type on physicochemical properties and stability of spearmint essential oil (Mentha spicata L.). J Mol Liq Stabilized Basil Seed Mucilage Nanoemulsion. 2022;359:119379.
Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pham. 1988;168(2):221–9.
Comments (0)